faricimab

The drug is used to treat neovascular (exudative) age-related macular degeneration, diabetic macular edema, as well as macular edema caused by retinal vein occlusion (branch or central).

Form: solution for injection

ATC: S01LA09

Manufacturer: F. Hoffmann-La Roche Ltd (Manufacturing of medicinal product (including filling/primary packaging), in-process control testing, quality control testing for release and stability, except microscopic method for particle determination, storage of medicinal product, secondary packaging, release of finished medicinal product)